Rare disease biopharmaceutical company
HR 4472 the BENEFIT Act; HR 7640 the HEART Act; S 4348 the Food & Drug Administration Safety and Landmark Advancements of 2022; HR 7667 the Food & Drug Administration Amendments of 2022; Ensuring access to treatments for rare disease; Value of rare disease research and development
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SPLITOAK STRATEGIES LLC
300 New Jersey Avenue, NW, Suite 900, Washington, DC, 20001, US
AMY JENSEN (1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Legislative Affairs) SARAH KUEHL EGGE (Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director, Joint Select Committee on Deficit Reduction)
1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Legislative Affairs Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director, Joint Select Committee on Deficit Reduction